Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: A phase III trial.

George P. Stathopoulos,D. Antoniou,J. Dimitroulis,J. Stathopoulos,K. Marosis,P Michalopoulou

Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: A phase III trial.

2010

George P. Stathopoulos
D. Antoniou
J. Dimitroulis
J. Stathopoulos
K. Marosis
P Michalopoulou

7579 Background: Liposomal cisplatin (Lipoplatin) was formed from cisplatin and liposomes composed of dipalmitoyl phosfatidyl glycerol (CPPG) soyphosphatidyl choline (5PC-3) cholesterol and methoxy...

Keywords:

Pathology
Oncology
Cisplatin
Paclitaxel
Liposomal Cisplatin
Response rate (survey)
Lung cancer
Medicine
Internal medicine
Pharmacology
Glycerol
Lipoplatin
Choline
Liposome
Cholesterol

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations